Context Therapeutics Inc.(CNTX)

Biotechnology · Philadelphia, PA

$0.32-0.01 (-4.37%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Context Therapeutics (CNTX) EV/EBIT: History & Chart | TGMCharts

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T21:26:09.418Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:26:09.418Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 29,566,719
Total debt · period ending 2026-06-30: 244,992
Cash · period ending 2026-06-30: 42,990,371
TTM operating income · period ending 2026-06-30: -48,726,416

FMP input reference: c88c4f39e0f2b8ce509c05ad310ef4a925915372bb385716b1b31bbca6f45484

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CNTX EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

CNTX Competitors' EV/EBIT Ratio

CNTX

Context Therapeutics Inc.

Current

Market Cap

$29.57M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRDX

GridAI Technologies Corp.

vs CNTX

Market Cap

$29.74M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QUCY

Quantum Cyber N.V.

vs CNTX

Market Cap

$29.37M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIRA

MIRA Pharmaceuticals, Inc.

vs CNTX

Market Cap

$29.91M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RMTI

Rockwell Medical, Inc.

vs CNTX

Market Cap

$30.19M

EV/EBIT Ratio

N/A

TTM Avg

85.48x

3Y Avg

85.48x

5Y Avg

85.48x

SCYX

SCYNEXIS, Inc.

vs CNTX

Market Cap

$30.44M

EV/EBIT Ratio

N/A

TTM Avg

0.97x

3Y Avg

0.97x

5Y Avg

0.97x

BYSI

BeyondSpring Inc.

vs CNTX

Market Cap

$28.47M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXH

MDxHealth S.A.

vs CNTX

Market Cap

$30.81M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONMD

OneMedNet Corporation

vs CNTX

Market Cap

$28.31M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRVO

CervoMed Inc.

vs CNTX

Market Cap

$30.92M

EV/EBIT Ratio

N/A

TTM Avg

0.37x

3Y Avg

0.82x

5Y Avg

0.82x

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Context Therapeutics Inc. (CNTX)	$29.57M	N/A	N/A	N/A	N/A
GridAI Technologies Corp. (GRDX)vs ›	$29.74M	N/A	N/A	N/A	N/A
Quantum Cyber N.V. (QUCY)vs ›	$29.37M	N/A	N/A	N/A	N/A
MIRA Pharmaceuticals, Inc. (MIRA)vs ›	$29.91M	N/A	N/A	N/A	N/A
Rockwell Medical, Inc. (RMTI)vs ›	$30.19M	N/A	85.48x	85.48x	85.48x
SCYNEXIS, Inc. (SCYX)vs ›	$30.44M	N/A	0.97x	0.97x	0.97x
BeyondSpring Inc. (BYSI)vs ›	$28.47M	N/A	N/A	N/A	N/A
MDxHealth S.A. (MDXH)vs ›	$30.81M	N/A	N/A	N/A	N/A
OneMedNet Corporation (ONMD)vs ›	$28.31M	N/A	N/A	N/A	N/A
CervoMed Inc. (CRVO)vs ›	$30.92M	N/A	0.37x	0.82x	0.82x

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

CNTX EV/EBIT Ratio Metrics

CNTX Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics